article thumbnail

Episode 354: Antiracism in Medicine – Episode 25 – Live from SGIM 2024: Best of Antiracism Research at the Society of General Internal Medicine’s 2024 Annual Meeting

The Clinical Problem Solvers

[link] CPSolvers: Anti-Racism in Medicine Series Episode 25 – Live from SGIM 2024: Best of Antiracism Research at the Society of General Internal Medicine’s 2024 Annual Meeting Show Notes by Ashley M. Clinician Response to Patient Medication Prices Displayed in the Electronic Health Record. September 19, 2024.

article thumbnail

Episode 384: Antiracism in Medicine – Episode 26 – Racial and Gender Health Disparities in Youth Suicide: Part 1

The Clinical Problem Solvers

These programs recognize the increasing difficulties in having to first see a community-based primary care provider before seeing a specialized psychiatrist. Accessed 2024. Diversifying your mental health outreach goes hand in hand with diversifying your providers. References Benton TD , Boyd RC , Njoroge WF. Ring the Alarm.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Be The Market: How Doctors Should Invest Their Money

The Motivated MD

I am not liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages. Best Index Funds Several investment platforms (Vanguard, Fidelity, Charles Schwab, USAA, etc.) offer index funds with low expense ratios.

Finance 52
article thumbnail

New Draft Guidance Provides Detailed (and Burdensome) Recommendations for Chemical Assessments to Support Medical Device Biocompatibility

FDA Law Blog

It is recommended to submit a Pre-Submission to the Agency when considering your chemical characterization strategy, especially for any devices/materials with special considerations or use of alternative strategies and solvents. FDA is extending the comment period on the notice published September 20, 2024 ( 89 FR 77162 ).

article thumbnail

Texas invests $50M in psychedelic drug research to treat addiction

Medical Xpress

A 2024 study published in the journal Nature Medicine found that military veterans with brain injuries saw major mental and physical improvements after just one ibogaine session. Ibogaine is a psychedelic that causes powerful hallucinations and can last for hours. In Brazil, the therapy has helped thousands.

article thumbnail

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

FDA Law Blog

As part of this change, the Coverage Gap Discount Program (CGDP), a program that has existed since 2011, will sunset on December 31, 2024, and be replaced by the Medicare Part D Manufacturer Discount Program (the “Discount Program”). Manufacturers must sign the agreement by March 1, 2024, to participate in the 2025 plan year.

article thumbnail

Rewiring the body clock: Deep brain imaging reveals unexpected complexity in jet lag adjustment

Medical Xpress

What is known is that special cells in the eye called intrinsically photosensitive retinal ganglion cells (ipRGCs) detect blue light and send signals to the SCN to reset the clock. But what happens inside the SCN after receiving this light signal has remained largely mysterious—until now.

Provider 109